Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.7650
+0.0680 (9.76%)
At close: Sep 1, 2026, 4:00 PM EDT
0.6885
-0.0765 (-10.00%)
Pre-market: Sep 2, 2026, 4:00 AM EDT
Barinthus Biotherapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Barinthus Biotherapeutics stock have an average target of $6.00, which predicts a 684.31% increase from the current stock price of 0.77.
Price Target: $6.00 (+684.31%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Barinthus Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 25, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +684.31% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.92
from -1.52
EPS Next Year
-1.14
from -0.92
EPS and Forward PE are based on non-GAAP adjusted numbers.